Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disease-Modifying Treatments for Transthyretin Amyloidosis.
Tushak ZJ, Cox SZ, Cei LF, Gwathmey KG, Shah KB. Tushak ZJ, et al. Among authors: shah kb. J Cardiovasc Pharmacol. 2021 Nov 1;78(5):e641-e647. doi: 10.1097/FJC.0000000000001115. J Cardiovasc Pharmacol. 2021. PMID: 34321398 Review.
Transthyretin Cardiac Amyloidosis in Black Americans.
Shah KB, Mankad AK, Castano A, Akinboboye OO, Duncan PB, Fergus IV, Maurer MS. Shah KB, et al. Circ Heart Fail. 2016 Jun;9(6):e002558. doi: 10.1161/CIRCHEARTFAILURE.115.002558. Circ Heart Fail. 2016. PMID: 27188913 Free PMC article. Review.
Light-chain cardiac amyloidosis.
Mankad AK, Sesay I, Shah KB. Mankad AK, et al. Among authors: shah kb. Curr Probl Cancer. 2017 Mar-Apr;41(2):144-156. doi: 10.1016/j.currproblcancer.2016.11.004. Epub 2016 Nov 17. Curr Probl Cancer. 2017. PMID: 28117074 Review.
Transthyretin Cardiac Amyloidosis.
Mankad AK, Shah KB. Mankad AK, et al. Among authors: shah kb. Curr Cardiol Rep. 2017 Aug 24;19(10):97. doi: 10.1007/s11886-017-0911-5. Curr Cardiol Rep. 2017. PMID: 28840452 Review.
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Maurer MS, et al. N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27. N Engl J Med. 2018. PMID: 30145929 Free article. Clinical Trial.
Higher levels of allograft injury in black patients early after heart transplantation.
Doshi A, Shah KB, Agbor-Enoh S, Tushak Z, Garcia V, Kong H, Jang MK, Hsu S, Feller ED, Rodrigo ME, Najjar SS, Tunc I, Yang Y, Lee S, Solomon MA, Berry G, Marboe C, Shah P, Valantine HA. Doshi A, et al. Among authors: shah kb, shah p. J Heart Lung Transplant. 2022 Jul;41(7):855-858. doi: 10.1016/j.healun.2021.12.006. Epub 2021 Dec 23. J Heart Lung Transplant. 2022. PMID: 35016813 Free PMC article.
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy.
Gillmore JD, Judge DP, Cappelli F, Fontana M, Garcia-Pavia P, Gibbs S, Grogan M, Hanna M, Hoffman J, Masri A, Maurer MS, Nativi-Nicolau J, Obici L, Poulsen SH, Rockhold F, Shah KB, Soman P, Garg J, Chiswell K, Xu H, Cao X, Lystig T, Sinha U, Fox JC; ATTRibute-CM Investigators. Gillmore JD, et al. Among authors: shah kb. N Engl J Med. 2024 Jan 11;390(2):132-142. doi: 10.1056/NEJMoa2305434. N Engl J Med. 2024. PMID: 38197816 Clinical Trial.
194 results